OREMAVEN
XMM 7,722.00 -2.63% YTD +5.6% OM ASX 450.55 -2.56% YTD +0.1% OM PRECIOUS 349.20 -2.24% YTD +2.5% OM EX-PREC 418.91 -2.72% YTD -1.1% XAU 4,115.59 +2.31% YTD -4.9% GLD 375.49 +0.81% YTD -5.2% GDX 85.75 +1.37% YTD -0.0% SIL 77.33 -1.00% YTD -7.3% COPX 70.23 -5.81% YTD -1.8% URNM 40.07 -2.79% YTD -27.0%
2026-11-06

← CRI management

Full background report

Mike Kevan

Interim Study Manager (continuation unconfirmed)

Career chronology

Suitability for the current role

Interim project-study manager appointment

2026-08 · analyst inference · medium materiality

Critica appointed Kevan interim study manager in August 2026 and said it would recruit a permanent general manager projects. His continuation after October’s study releases was not independently confirmed.

Attribution: Responsibility not applicable. Issuer directly identifies the interim appointment; evaluation of fit is inference and continuation is uncertain.

Relevance: Study integration experience is relevant to project development, but role continuity remains uncertain.

Critica strengthens project development team (pp.1–2 appointment and reported experience); Critica September 2026 quarterly activities report (pp.1–2 completion of studies)

Evidence gaps

  • Whether the interim engagement continued after October 2026 is unconfirmed.

  • Exact prior employers, roles, credentials and attributable project outcomes remain incompletely researched.

  • Individual searches and source reviews were limited; broad name-based queries were reused across multiple topics, and separate topic-specific checks were not completed for every category.